A carregar...
PD-1/PD-L1 Blockade in Renal Cell Cancer
INTRODUCTION: Immunotherapy using checkpoint inhibitors is providing significant benefit to patients with renal cell carcinoma (RCC), both in overall survival and tolerability of treatment. Given the recent approval of the first checkpoint inhibitor in RCC, this review discusses the background and c...
Na minha lista:
| Publicado no: | Expert Rev Clin Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5555220/ https://ncbi.nlm.nih.gov/pubmed/27426025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2016.1214575 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|